Abstract:The onset and mechanisms underlying neurodegenerative diseases remain uncertain. The main features of neurodegenerative diseases have been related with cellular and molecular events like neuronal loss, mitochondrial dysfunction and aberrant accumulation of misfolded proteins or peptides in specific areas of the brain. The most prevalent neurodegenerative diseases belonging to age-related pathologies are Alzheimer's disease, Huntington's disease, Parkinson's disease and amyotrophic lateral sclerosis. Interestingly, mitochondrial dysfunction has been observed to occur during the early onset of several neuropathological events associated to neurodegenerative diseases. The master regulator of mitochondrial quality control and energetic metabolism is the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). Additionally, it has been observed that PGC-1α appears to be a key factor in maintaining neuronal survival and synaptic transmission. In fact, PGC-1α downregulation in different brain areas (hippocampus, substantia nigra, cortex, striatum and spinal cord) that occurs in function of neurological damage including oxidative stress, neuronal loss, and motor disorders has been seen in several animal and cellular models of neurodegenerative diseases. Current evidence indicates that PGC-1α upregulation may serve as a potent therapeutic approach against development and progression of neuronal damage. Remarkably, increasing evidence shows that PGC-1α deficient mice have neurodegenerative diseases-like features, as well as neurological abnormalities. Finally, we discuss recent studies showing novel specific PGC-1α isoforms in the central nervous system that appear to exert a key role in the age of onset of neurodegenerative diseases and have a neuroprotective function in the central nervous system, thus opening a new molecular strategy for treatment of neurodegenerative diseases. The purpose of this review is to provide an up-to-date overview of the PGC-1α role in the physiopathology of neurodegenerative diseases, as well as establish the importance of PGC-1α function in synaptic transmission and neuronal survival.

Epigenetic codes of mitochondrial homeostasis

The transcriptional coactivator CBP/p300 is an evolutionarily conserved node that promotes longevity in response to mitochondrial stress

Mtorc1 Phosphorylates Acetyltransferase P300 to Regulate Autophagy and Lipogenesis.

Mitochondrial dysfunction-induced H3K27 hyperacetylation perturbs enhancers in Parkinson's disease

Mitochondrial Control of Innate Immune Responses

PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling

Histone deacetylase HDA-1 modulates mitochondrial stress response and longevity

Mitochondrial acetyl-CoA reversibly regulates locus-specific histone acetylation and gene expression

Emerging roles of p300/CBP in autophagy and autophagy-related human disorders

Mitochondrial stress-induced H4K12 hyperacetylation dysregulates transcription in Parkinson's disease

Crosstalk between mitochondrial biogenesis and mitophagy to maintain mitochondrial homeostasis

NuRD Mediates Mitochondrial Stress–induced Longevity Via Chromatin Remodeling in Response to Acetyl-Coa Level

Mitochondrial-to-nuclear Communication in Aging: an Epigenetic Perspective.

Mitochondrial membrane potential regulates nuclear DNA methylation and gene expression through phospholipid remodeling

Germline regulation of the somatic mitochondrial stress response

A peep into mitochondrial disorder: multifaceted from mitochondrial DNA mutations to nuclear gene modulation

Epigenetic reprogramming of mtDNA and its etiology in mitochondrial diseases

MITOCHONDRIAL SYSTEM BIOLOGY AS A WINDOW INTO DISEASES OF AGING

Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors

Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure

A mitochondrial FUNDC1/HSC70 interaction organizes the proteostatic stress response at the risk of cell morbidity.